• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vor Biopharma Inc. - Common Stock (NQ:VOR)

20.31 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vor Biopharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
May 02, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
April 05, 2024
 
Via Benzinga
News headline image
Vor Biopharma: Q4 Earnings Insights ↗
March 20, 2024
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Vor Biopharma ↗
August 14, 2023
 
Via Benzinga
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
April 01, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness ↗
March 28, 2024
Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements. 
Via InvestorPlace
News headline image
VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023 ↗
March 20, 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 20, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
March 04, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
January 17, 2024
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit
November 27, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
November 09, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update
November 07, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
November 03, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform
November 02, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
October 03, 2023
  On Tuesday, 647 companies set new 52-week lows. 
Via Benzinga
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
September 25, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
September 21, 2023
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
September 19, 2023
  During Tuesday's session, 275 companies made new 52-week lows. 
Via Benzinga
News headline image
Vor Bio to Participate in Upcoming Investor Conferences
August 30, 2023
From Vor Biopharma
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
August 11, 2023
  During the Friday's sesion, 157 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Vor Bio Reports Second Quarter 2023 Financial Results and Provides Company Update
August 10, 2023
From Vor Biopharma
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap